Sleep Apnea Implants Market
Market Insights on Sleep Apnea Implants covering sales outlook, demand forecast & up-to-date key trends
Sleep Apnea Implants Market by Product (Phrenic Nerve Stimulator, Hypoglossal Neurostimulation Devices, Bone Screw Implant System, Flexible Tongue Retractor System, Palatal Implants/Pillar Procedure), Indication), End User & Region - Forecast to 2021-2031
About the Report
[229 Pages Report] The rising prevalence of sleep deprivation disorders such as obstructive sleep apnea (OSA), a severe sleep disorder that may increase the risk of fatal accidents or other health-related complications caused due to disturbed sleep, has necessitated innovation in Sleep Apnea Implants. Consequences of sleepiness and sleep deprivation are common among people who are shift workers and have headed to several sleep-related disorders. Problems such as OSA, insomnia, jet lag narcolepsy, and sleepwalking are a few of the sleep-related disorders which remain undiagnosed. For instance, according to a study published in the National Institutes of Health journal, around 30% of the adult U.S. population suffer from insomnia and 10% from chronic
A large pool of the population affected by sleep apnea have become more awareness about these disorders and other related ailments. The increasing prevalence of sleep disorders has led to expansion in hospitals and other care centers in various areas, with the establishment of separate divisions dealing with sleep disorders. These sleep centers have increased awareness on tracking sleep patterns for better sleep. Sleep-related awareness is consistently contributing to the increase in the diagnosis rate of sleep disorders. This is expected to drive the sleep apnea implants market.
In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI) offers insights about key factors driving the demand for sleep apnea implants. The report tracks the global sales of sleep apnea implants in 20+ high-growth markets, along with analyzing the impact COVID-19 has had on the medical device industry in general, and sleep apnea implants in particular.
Let us know your requirement to get
100% FREE customization
What is the Future Outlook for Sleep Apnea Implants Market in Comparison to Historical Growth?
OSA is a progressive disorder affecting more than 200 million people worldwide. According to a study in Lancet, 936 million (95% CI 903–970) adults aged 30–69 years (men and women) were suffering from mild to severe OSA globally. The highest number of affected cases were found in China, followed by the USA, Brazil, and India in 2019.
According to FMI’s analysis, sales of sleep apnea implants have grown at a 19.0% CAGR between 2015 and 2019. Sleep apnea implants have become a potential tool improving airflow and reducing sleep apnea in patients suffering from a sleep disorder. Hypoglossal neurostimulation devices have gained popularity based on their efficacy as compared to other products.
The COVID-19 pandemic has significantly affected medical practices, resulting in a decrease in surgical procedures and therapies across the world. Nonetheless, FMI expects the global sleep apnea implants market to grow at a 17.3% CAGR through 2031.
What are the Opportunities in the Sleep Apnea Implants Market?
Manufacturers are actively focusing on research and development to innovate advanced devices that meet the customers’ demand and are likely to gain popularity with high revenue share in the competitive market. Advancements in sleep apnea devices include sleep trackers that track sleep patterns based on movement monitoring and also monitor the heart rate. For example, many companies are developing wearables that go on your wrist or finger while sleeping and collect data about the movement and heart rate, while some also track breathing patterns.
Furthermore, developing countries, such as China and India, have a relatively large population base and the incidence of sleep-related disorders such as insomnia and sleep apnea is comparatively higher than that in other countries. Sleep-related disorders are a serious issue in China and India, which is an opportunity for the leading manufacturers to expand their business in the region and increase their market share. Thus, the rising prevalence of sleep-related disorders is expected to offer robust opportunities for the manufacturers in the sleep apnea implants market.
What is the Impact of Government and Non-governmental Initiatives on Sleep Apnea Implants Sales?
Various government and non-government organizations such as Circadian Sleep Disorders Network and the American Sleep Apnea Association (ASAA) conduct sleep awareness programs regarding the importance of ample sleep and usage of sleep apnea devices. These organizations are launching several awareness programs to educate people about sleep hygiene and technological aid to get better sleep. For example, Sleep Awareness Week was celebrated by the National Sleep Foundation with the theme “Begin with Sleep Moreover” in March 2018.
Various organizations are improving their services to offer greater customer satisfaction. For instance, the American Sleep Association is an organization dedicated to improving public health by increasing awareness about the importance of sleep and the dangers of sleep disorders. Furthermore, government approval is expected to propel the sleep apnea implants market growth.
Due to an increase in the need for assessment of OSA breathe in peripheral artery disease and limb ischemia, many manufacturers seek 510(k) Premarket Notification from the U.S. Food and Drug Administration (“FDA”) which demonstrates the device to be safe and effective, equivalent to a legally marketed device. For example, in May 2019, Siesta Medical, Inc. (Private) announced FDA clearance for expanded indications for its Encore™ Tongue Suspension System for the treatment of obstructive sleep apnea.
Additionally, implementing government guidelines for prescription reformation attracts end-users, which is expected to boost the demand for sleep apnea implants. For instance, in February 2021, the FDA authorized the marketing of eXciteOSA® (Signifier Medical Technologies), a new prescription intended to reduce sleep snoring and OSA in patients 18 years and older.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat are Factors Impeding Sleep Apnea Implants Sales?
Continuous positive airway pressure (CPAP) is the most popular technology adopted for the assessment of sleep deprivation-associated disorders. CPAP devices come in different price ranges depending upon the number of features. The high upfront cost can have a negative impact on the end users’ decision to purchase sleep apnea implants.
Some of the most effective sleep disorder treatments are quite expensive. As a general rule, the surgery associated with the placement of the Inspire hypoglossal nerve stimulator may cost $30,000 to $40,000 (with the device itself costing about $20,000 of this total). Thus, high cost of the technology as well as the treatment are the major factor expected to hamper the market growth.
What is the impact of COVID-19 on the Sleep Apnea Implants Market?
The COVID-19 pandemic caused a huge disturbance in almost every sector across the world. The pandemic is expected to continue to adversely impact the revenue due to decrease and delays in the number of sleep apnea therapy procedures performed and patients screened for eligibility for therapy. Beginning in the second week of March 2020, essentially all of the scheduled therapy procedures were postponed and numerous other authorized cases were unable to be scheduled. The widespread halt in elective surgical procedures continued.
During the period in which surgical procedures were significantly limited, Inspire identified and implemented innovative solutions to support patients, as well as educating patients with sleep apnea, attracting patients to reach out to learn more about the therapy and get connected to a healthcare provider. Many companies are supporting this interaction through the use of several virtual tools, such as the new Inspire Sleep app, and other online tools.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Country-wise Insights
How Large is the Opportunity in the US?
The healthcare system of the U.S. is highly renowned for its well-developed infrastructure and high expenditure. The care regimes in the care centers and hospitals are covered by regulatory rules and insurance policies. The massive hospital bills incurred other than Medicare escalate the market in the country.
The U.S. government and regulatory bodies are actively adopting several cost-containment plans to reduce their healthcare burden. The shift from a volume-based to a value-based system is majorly driven by the various measures undertaken by providers, governments, biotechnology companies, and insurance payers. Some of the measures are outcome-based profits, pricing, risk-sharing, competitive tendering, and price control.
A value-based healthcare system will not only provide improved outcomes through integrated care pathways, but also levy pricing pressure on medical device companies, and this is likely to impact investments in the R&D of advanced medical treatment technologies. In June 2020, the IDE trial was approved by FDA, with the first US and international implants.
Furthermore, due to the high prevalence of sleep disorders in the U.S., the government as well as non-government organizations are conducting campaigns to raise general awareness among people suffering from these diseases. This is likely to support the overall market growth in the country.
Why is Innovation the Key to Succeed in the German Medical Device Market?
The Federal Statistical Office has reported that healthcare spending in Germany rose by 4% in 2018 from 2017. In 2018, the country’s healthcare spending accounted for 11.7% of the GDP. Furthermore, health expenditure was expected to surge to 407.4 billion euros by 2019, presenting a lucrative landscape for the expansion of sleep apnea implants sales.
Also, the presence of domestic players such as Carl Martin GmbH is supporting the expansion in Germany. The company has been investing significantly in expansion efforts.
Since 2009, health insurance has been made mandatory for all citizens of the country. According to NCBI, a total of 70 million people, which roughly covers 85% of the population, are covered by statutory health insurance. Another 11% of the population of Germany is covered by substitutive private health insurance. Conducive reimbursement policies and regulatory scenario are presenting attractive growth opportunities.
Rising Disposable Income in China to Create a Surge
Increasing disposable income can have a significant impact on the development of the economy in emerging countries, which results in the affordability of proper healthcare treatments. China’s per capita disposable income reached about 4,961 U.S. dollars in 2020, more than double that in 2010. The potential for high healthcare insurance and rising disposable income will contribute to increasing affordability of healthcare services and also accessibility to expensive equipment for the treatment of diseases. The market in China is expected to witness significant growth at a CAGR of around 19.6% during the forecast period.
What are the Restraints that GCC Countries Face in Sleep Apnea Implants?
Lack of awareness about complete sleep and related disorders and lack of treatment or low adoption of therapy due to high cost raises the prevalence of sleep disorders in GCC Countries. Due to limited campaigning and assessment of the undiagnosed disorders, there seems to occur less usage of these devices in hospitals in GCC Countries. Moreover, poor healthcare facilities in some countries restrain the growth of the sleep apnea implants market. Due to financial burdens, governments fail to provide proper treatment and are unable to facilitate campaigns to create awareness among the population, which may impact the usage of advanced devices. The market in GCC Countries is expected to witness sluggish growth at a CAGR of just around 21%.
Category-wise Insights
What’s the Market Share of OSA?
The OSA segment will continue to grow and dominate the market during the forecast period. According to FMI, the segment is expected to hold more than 90% of the market share, in terms of indication, by the end of 2031. OSA is the most common sleep-related breathing disorder and is characterized by recurrent episodes of complete or partial obstruction of the upper airway leading to reduced or absent breathing during sleep. The rising prevalence of OSA across the global population leads to a spike in share for the OSA segment in the market.
Why Hypoglossal Neurostimulation Devices Dominated The Sleep Apnea Implants Market?
Hypoglossal Neurostimulation Devices hold the highest share in the sleep apnea implants market. Hypoglossal Neurostimulation Devices is meant to treat pharyngeal tone and stimulates genioglossus protrusion to the open airway by the tongue during sleep. These devices reduce the risk for severe dysphagia and throat pain that witnessed by a surge in the demand for the device in the market.
How Are Hospital Influencing Sleep Apnea Implants Sales?
The hospital segment is expected to dominate the sleep apnea implants market through the forecast period. Higher footfall of sleep apnea patients in hospitals will seal their position as the dominant end user.
Competitive Landscape
Some of the leading companies operating in the sleep apnea implants market are aiming to invest in the market to expand their offering and business profile across the countries. For instance, in April 2021, a subsidiary of Asahi Kasei Company, ZOLL Medical Corporation, acquired Respicardia, Inc. to combine its cardiac and respiratory care expertise with Respicardia’s novel remed?® system to make a meaningful difference in the health and quality of life for many patients.
Various companies are entering into strategic collaborations and acquisitions with the leading pharmaceutical companies to address the requirements of an expanding patient pool. Most of the players are focusing on innovations, developments, product launches and regulatory approvals to increase sales of sleep apnea implants worldwide. For instance, in March 2021, Inspire Medical Systems, Inc. received FDA approval for their improved surgical implant procedure for Inspire Upper Airway Therapy for OSA. The newly approved procedure eliminates one incision with a revised placement of the pressure sensing lead - and reduces the average procedure time for Inspire therapy by approximately 20%.
Some of the leading companies operating in the market are:
- Inspire Medical Systems
- Respicardia, Inc.
- Medtronic Plc
- LinguaFlex LLC
- Siesta Medical, Inc.
- Pillar Palatal LLC/ The Snoring Center
- Nyxoah SA
- LivaNova/ImThera
*The list is not exhaustive, and only for representational purposes. Full competitive intelligence with SWOT analysis available in the report.
Scope of the Report
|
Attribute |
Details |
|
Forecast Period |
2021-2031 |
|
Historical Data Available for |
2016-2020 |
|
Market Analysis |
Volume (Units), Pricing Analysis, USD Million for Value |
|
Key Countries Covered |
US, Canada, Germany, Brazil, U.K., Germany, France, Spain, Italy, China, Japan, India, Indonesia, Australia, GCC Countries |
|
Key Segments Covered |
Product Type, Indication, End User, and Region |
|
Key Companies Profiled |
|
|
Report Coverage |
Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
|
Customization & Pricing |
Sleep Apnea Implants Market by Category
Product
- Phrenic Nerve Stimulator
- Hypoglossal Neurostimulation Devices
- Bone Screw Implant System
- Flexible Tongue Retractor System
- Palatal Implants/Pillar Procedure
Indication
- Central Sleep Apnea
- Obstructive Sleep Apnea (OSA)
End User
- Hospitals
- Ambulatory Surgical Centers
- Office Based Clinics
Region
- North America
- Latin America
- Europe
- East Asia
- South Asia
- The Middle East and Africa (MEA)
- Oceania
Frequently Asked Questions
Which is the most lucrative market for sleep apnea implants?
The U.S. currently leads the global market for sleep apnea implants owing to the presence of well-developed healthcare facilities and some of the leading leading players in the country. Sales in the U.S. will account for over 95% of total global demand throughout the forecast period
Which is the top-selling sleep apnea implant?
Hypoglossal neurostimulation devices are dominating the market as compared to other sleep apnea implant products owing to being an advanced, minimally invasive solution and an entirely different approach to treat OSA.
Which are some of the leading companies offering sleep apnea implants?
Some of the leading companies offering sleep apnea implants are Inspire Medical Systems, Respicardia, Inc., Medtronic Plc, LinguaFlex LLC, Siesta Medical, Inc., Pillar Palatal LLC/The Snoring Center, Nyxoah SA, LivaNova/ImThera, and others.
Who is the leading end user of sleep apnea implants?
Hospitals are leading the end-user segment of the sleep apnea implants market, owing to their advanced medical facilities and higher flow of patients for diagnosis and treatment.
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Market Background 4.1. Macro-Economic Factors 4.1.1. Global GDP Growth Outlook 4.1.2. Global Healthcare Expenditure Outlook 4.1.3. Per-Capita Healthcare Expenditure 4.1.4. Disposable Income 4.2. Forecast Factors - Relevance & Impact 4.2.1. Increasing Prevalence of OSA 4.2.2. Treatment Seeking Rate (%) 4.2.3. Cost Per Device 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 5. Market Context 5.1. Disease Epidemiology of Sleep Apnea By Region 5.2. Key Procedure Statistics 5.3. Parent Market Analysis 5.4. Growth strategies and Promotional Activities implemented by Market Players 5.5. Procedure Statistics for Sleep Apnea Management 5.6. Regulatory Scenario 5.7. Reimbursement Landscape 6. COVID19 Crisis Analysis 6.1. Current GDP Projection and Probable Impact 6.2. Current Economic Projection as compared to 2008 financial analysis 6.3. COVID19 and Impact Analysis 6.3.1. Revenue By Product 6.3.2. Revenue By Country 6.4. 2020 Market Scenario 6.5. Recovery Scenario – Short term, Midterm and Long Term Impact 7. Global Market Volume Analysis 2016-2020 and Forecast, 2021-2031 7.1. Historical Market Volume Analysis, 2016-2020 7.2. Current and Future Market Volume Projections, 2021-2031 7.2.1. Y-o-Y Growth Trend Analysis 8. Global Market - Pricing Analysis 8.1. Regional Pricing Analysis, By Products 8.2. Global Average Pricing Analysis Benchmark 9. Global Market Value (US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031 9.1. Historical Market Value (US$ Mn) Analysis, 2016-2020 9.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Opportunity Analysis, 2021-2031 10. Global Market Analysis 2016-2020 and Forecast 2021-2031, By Products 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Products, 2016–2020 10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Products, 2021-2031 10.3.1. Phrenic Nerve Stimulator 10.3.2. Hypoglossal Neurostimulation Devices 10.3.3. Bone Screw Implant System 10.3.4. Flexible Tongue Retractor System 10.3.5. Palatal Implants / Pillar Procedure 10.4. Market Attractiveness Analysis, By Products 11. Global Market Analysis 2016-2020 and Forecast 2021-2031, By Indications 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Analysis, By Indications, 2016–2020 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indications, 2021-2031 11.3.1. Central Sleep Apnea 11.3.2. Obstructive Sleep Apnea (OSA) 11.4. Market Attractiveness Analysis, By Indications 12. Global Market Analysis 2016-2020 and Forecast 2021-2031, By End User 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Mn) and Analysis, By End User, 2016–2020 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2021-2031 12.3.1. Hospitals 12.3.2. Ambulatory Surgical Centers 12.3.3. Office Based Clinics 12.4. Market Attractiveness Analysis, By End User 13. Global Market Analysis 2016-2020 and Forecast 2021-2031, by Region 13.1. Introduction / Key Findings 13.2. Historical Market Size (US$ Mn) Volume (Units) Analysis, By Region, 2016–2020 13.3. Current and Future Market Size (US$ Mn) Volume (Units) Analysis and Forecast By Region, 2021-2031 13.3.1. North America 13.3.2. Latin America 13.3.3. Europe 13.3.4. East Asia 13.3.5. South Asia 13.3.6. Oceania 13.3.7. Middle East and Africa 13.4. Market Attractiveness Analysis, By Region 14. North America Market Analysis 2016-2020 and Forecast 2021-2031 14.1. Introduction 14.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market Taxonomy, 2016–2020 14.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2021-2031 14.3.1. By Country 14.3.1.1. U.S. 14.3.1.2. Canada 14.3.2. By Products 14.3.3. By Indications 14.3.4. By End User 14.4. Market Attractiveness Analysis 15. Latin America Market Analysis 2016-2020 and Forecast 2021-2031 15.1. Introduction 15.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2016–2020 15.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2021-2031 15.3.1. By Country 15.3.1.1. Brazil 15.3.1.2. Mexico 15.3.1.3. Argentina 15.3.1.4. Rest of Latin America 15.3.2. By Products 15.3.3. By Indications 15.3.4. By End User 15.4. Market Attractiveness Analysis 16. Europe Market Analysis 2016-2020 and Forecast 2021-2031 16.1. Introduction 16.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market Taxonomy, 2016–2020 16.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2021-2031 16.3.1. By Country 16.3.1.1. Germany 16.3.1.2. Italy 16.3.1.3. France 16.3.1.4. U.K. 16.3.1.5. Spain 16.3.1.6. BENELUX 16.3.1.7. Russia 16.3.1.8. Rest of Europe 16.3.2. By Products 16.3.3. By Indications 16.3.4. By End User 16.4. Market Attractiveness Analysis 17. South Asia Market Analysis 2016-2020 and Forecast 2021-2031 17.1. Introduction 17.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market Taxonomy, 2016–2020 17.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2021-2031 17.3.1. By Country 17.3.1.1. India 17.3.1.2. Thailand 17.3.1.3. Indonesia 17.3.1.4. Malaysia 17.3.1.5. Rest of South Asia 17.3.2. By Products 17.3.3. By Indications 17.3.4. By End User 17.4. Market Attractiveness Analysis 18. East Asia Market Analysis 2016-2020 and Forecast 2021-2031 18.1. Introduction 18.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market Taxonomy, 2016–2020 18.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2021-2031 18.3.1. By Country 18.3.1.1. China 18.3.1.2. Japan 18.3.1.3. South Korea 18.3.2. By Products 18.3.3. By Indications 18.3.4. By End User 18.4. Market Attractiveness Analysis 19. Oceania Market Analysis 2016-2020 and Forecast 2021-2031 19.1. Introduction 19.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market Taxonomy, 2016–2020 19.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2021-2031 19.3.1. By Country 19.3.1.1. Australia 19.3.1.2. New Zealand 19.3.2. By Products 19.3.3. By Indications 19.3.4. By End User 19.4. Market Attractiveness Analysis 19.5. Key Market Participants - Intensity Mapping 19.6. Drivers and Restraints - Impact Analysis 20. Middle East and Africa Market Analysis 2016-2020 and Forecast 2021-2031 20.1. Introduction 20.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market Taxonomy, 2016–2020 20.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2021-2031 20.3.1. By Country 20.3.1.1. GCC Countries 20.3.1.2. Turkey 20.3.1.3. South Africa 20.3.1.4. Rest of Middle East and Africa 20.3.2. By Products 20.3.3. By Indications 20.3.4. By End User 20.4. Market Attractiveness Analysis 20.5. Key Market Participants - Intensity Mapping 20.6. Drivers and Restraints - Impact Analysis 21. Key and Emerging Countries Market Analysis 2016-2020 and Forecast 2021-2031 21.1. Introduction 21.1.1. Market Value Proportion Analysis, By Key Countries 21.1.2. Global Vs. Country Growth Comparison 21.2. U.S. Market Analysis 21.2.1. By Products 21.2.2. By Indications 21.2.3. By End User 21.3. Canada Market Analysis 21.3.1. By Products 21.3.2. By Indications 21.3.3. By End User 21.3.4. By End User 21.4. Brazil Market Analysis 21.4.1. By Products 21.4.2. By Indications 21.4.3. By End User 21.5. U.K. Market Analysis 21.5.1. By Products 21.5.2. By Indications 21.5.3. By End User 21.6. Germany Market Analysis 21.6.1. By Products 21.6.2. By Indications 21.6.3. By End User 21.7. France Market Analysis 21.7.1. By Products 21.7.2. By Indications 21.7.3. By End User 21.8. Italy Market Analysis 21.8.1. By Products 21.8.2. By Indications 21.8.3. By End User 21.9. Spain Market Analysis 21.9.1. By Products 21.9.2. By Indications 21.9.3. By End User 21.10. China Market Analysis 21.10.1. By Products 21.10.2. By Indications 21.10.3. By End User 21.11. Japan Market Analysis 21.11.1. By Products 21.11.2. By Indications 21.11.3. By End User 21.12. India Market Analysis 21.12.1. By Products 21.12.2. By Indications 21.12.3. By End User 22. Market Structure Analysis 22.1. Market Analysis, By Tier of Companies 22.2. Market Share Analysis of Top Players (%) 22.3. Market Presence Analysis 22.3.1. Regional Footprint by Players 22.3.2. Product Foot print by Players 23. Competition Analysis 23.1. Competition Dashboard 23.2. Competition Benchmarking 23.3. Competition Deep Dive (Tentative List) 23.3.1. Inspire Medical Systems 23.3.1.1. Overview 23.3.1.2. Product Portfolio 23.3.1.3. SWOT Analysis 23.3.1.4. Sales Footprint 23.3.1.5. Strategy Overview 23.3.1.5.1. Marketing Strategy 23.3.1.5.2. Product Strategy 23.3.1.5.3. Channel Strategy 23.3.2. Respicardia, Inc 23.3.2.1. Overview 23.3.2.2. Product Portfolio 23.3.2.3. SWOT Analysis 23.3.2.4. Sales Footprint 23.3.2.5. Strategy Overview 23.3.2.5.1. Marketing Strategy 23.3.2.5.2. Product Strategy 23.3.2.5.3. Channel Strategy 23.3.3. Medtronic Plc 23.3.3.1. Overview 23.3.3.2. Product Portfolio 23.3.3.3. SWOT Analysis 23.3.3.4. Sales Footprint 23.3.3.5. Strategy Overview 23.3.3.5.1. Marketing Strategy 23.3.3.5.2. Product Strategy 23.3.3.5.3. Channel Strategy 23.3.4. LinguaFlex LLC 23.3.4.1. Overview 23.3.4.2. Product Portfolio 23.3.4.3. SWOT Analysis 23.3.4.4. Sales Footprint 23.3.4.5. Strategy Overview 23.3.4.5.1. Marketing Strategy 23.3.4.5.2. Product Strategy 23.3.4.5.3. Channel Strategy 23.3.5. Siesta Medical, Inc 23.3.5.1. Overview 23.3.5.2. Product Portfolio 23.3.5.3. SWOT Analysis 23.3.5.4. Sales Footprint 23.3.5.5. Strategy Overview 23.3.5.5.1. Marketing Strategy 23.3.5.5.2. Product Strategy 23.3.5.5.3. Channel Strategy 23.3.6. Pillar Palatal LLC / The Snoring Center 23.3.6.1. Overview 23.3.6.2. Product Portfolio 23.3.6.3. SWOT Analysis 23.3.6.4. Sales Footprint 23.3.6.5. Strategy Overview 23.3.6.5.1. Marketing Strategy 23.3.6.5.2. Product Strategy 23.3.6.5.3. Channel Strategy 23.3.7. Nyxoah SA 23.3.7.1. Overview 23.3.7.2. Product Portfolio 23.3.7.3. SWOT Analysis 23.3.7.4. Sales Footprint 23.3.7.5. Strategy Overview 23.3.7.5.1. Marketing Strategy 23.3.7.5.2. Product Strategy 23.3.7.5.3. Channel Strategy 23.3.8. LivaNova/ImThera 23.3.8.1. Overview 23.3.8.2. Product Portfolio 23.3.8.3. SWOT Analysis 23.3.8.4. Sales Footprint 23.3.8.5. Strategy Overview 23.3.8.5.1. Marketing Strategy 23.3.8.5.2. Product Strategy 23.3.8.5.3. Channel Strategy 24. Assumptions and Acronyms Used 25. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product Type Table 02: Global Market Size (‘000 Units) Analysis 2016-2020 and Forecast 2021-2031, By Product Type Table 03: Global Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication Table 04: Global market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User Table 05: Global Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Region Table 06: North America Market Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Product Type Table 07: North America Market Volume (units) Analysis 2016–2020 and Forecast 2021–2031, By Product Type Table 08: North America Market Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Indication Table 09: North America Market Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By End User Table 10: North America Market Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Country Table 11: Latin America Market Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Product Type Table 12: Latin America Market Volume (units) Analysis 2016–2020 and Forecast 2021–2031, By Product Type Table 13: Latin America Market Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Indication Table 14: Latin America Market Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By End User Table 15: Latin America Market Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Country Table 16: Europe Market Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Product Type Table 17: Europe Market Volume (units) Analysis 2016–2020 and Forecast 2021–2031, By Product Type Table 18: Europe Market Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Indication Table 19: Europe Market Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By End User Table 20: Europe Market Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Country Table 21: South Asia Market Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Product Type Table 22: South Asia Market Volume (units) Analysis 2016–2020 and Forecast 2021–2031, By Product Type Table 23: South Asia Market Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Indication Table 24: South Asia Market Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By End User Table 25: South Asia Market Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Country Table 26: East Asia Market Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Product Type Table 27: East Asia Market Volume (units) Analysis 2016–2020 and Forecast 2021–2031, By Product Type Table 28: East Asia Market Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Indication Table 29: East Asia Market Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By End User Table 30: East Asia Market Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Country Table 31: Oceania Market Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Product Type Table 32: Oceania Market Volume (units) Analysis 2016–2020 and Forecast 2021–2031, By Product Type Table 33: Oceania Market Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Indication Table 34: Oceania Market Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By End User Table 35: Oceania Market Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Country Table 36: Middle East and Africa Market Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Product Type Table 37: Middle East and Africa Market Volume (units) Analysis 2016–2020 and Forecast 2021–2031, By Product Type Table 38: Middle East and Africa Market Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Indication Table 39: Middle East and Africa Market Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By End User Table 40: Middle East and Africa Market Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Country
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Market Historical Market Volume (units) Analysis, 2016-2020 Figure 02: Global Current and Future Market Volume (units), 2021-2031 & Y-o-Y Growth Trend Analysis Figure 03: Phrenic Nerve Stimulator Pricing Analysis (US$) Per Device, By Region, 2020 Figure 04: Hypoglossal Neurostimulation Devices Pricing Analysis (US$) Per Device, By Region, 2020 Figure 05: Bone Screw Implant System Pricing Analysis (US$) Per Device, By Region, 2020 Figure 06: Palatal Implants / Pillar Procedure Pricing Analysis (US$) Per Device, By Region, 2020 Figure 07: Global Market Historical Market Value (US$ Mn) Analysis, 2016-2020 Figure 08: Global Current and Future Market Value (US$ Mn), 2021-2031 & Y-o-Y Growth Trend Analysis Figure 09: Market Absolute $ Opportunity, 2021–2031 Figure 10: Global Market Share Analysis (%) By Product Type, 2021 & 2031 Figure 11: Global Market Y-o-Y Growth (%) By Product Type, 2021-2031 Figure 12: Global Market Attractiveness Analysis, By Product Type (2021-2031) Figure 13: Global Market Share Analysis (%) By Indication, 2021 & 2031 Figure 14: Global Market Y-o-Y Growth (%) By Indication, 2021-2031 Figure 15: Global Market Attractiveness Analysis, By Indication Figure 16: Global Market Share Analysis (%) By End User, 2021 & 2031 Figure 17: Global Market Y-o-Y Growth (%) By End User, 2021-2031 Figure 18: Global Market Attractiveness Analysis, By End User Figure 19: Global Market Share Analysis (%) By Region, 2021 & 2031 Figure 20: Global Market Y-o-Y Growth (%) By Region, 2021-2031 Figure 21: Global Market Attractiveness Analysis, By Region Figure 22: North America Market Share, By Product Type (2021) Figure 23: North America Market Share, By Indication (2021) Figure 24: North America Market Share, By End User (2021) Figure 25: North America Market Share, By Country (2021) Figure 26: North America Market Value (US$ Mn) Analysis, 2016-2020 Figure 27: North America Market Value (US$ Mn) & Y-o-Y Growth (%), 2021-2031 Figure 28: North America Market Attractiveness Analysis, By Product Type, 2021–2031 Figure 29: North America Market Attractiveness Analysis, By Indication, 2021–2031 Figure 30: North America Market Attractiveness Analysis, By End User, 2021–2031 Figure 31: North America Market Attractiveness Analysis, By Country, 2020–2030 Figure 32: Latin America Market Share, By Product Type (2021) Figure 33: Latin America Market Share, By Indication (2021) Figure 34: Latin America Market Share, By End User (2021) Figure 35: Latin America Market Share, By Country (2021) Figure 36: Latin America Market Value (US$ Mn) Analysis, 2016-2020 Figure 37: Latin America Market Value (US$ Mn) & Y-o-Y Growth (%), 2021-2031 Figure 38: Latin America Market Attractiveness Analysis, By Product Type, 2021–2031 Figure 39: Latin America Market Attractiveness Analysis, By Indication, 2021–2031 Figure 40: Latin America Market Attractiveness Analysis, By End User, 2021–2031 Figure 41: Latin America Market Attractiveness Analysis, By Country, 2020–2030 Figure 42: Europe Market Share, By Product Type (2021) Figure 43: Europe Market Share, By Indication (2021) Figure 44: Europe Market Share, By End User (2021) Figure 45: Europe Market Share, By Country (2021) Figure 46: Europe Market Value (US$ Mn) Analysis, 2016-2020 Figure 47: Europe Market Value (US$ Mn) & Y-o-Y Growth (%), 2021-2031 Figure 48: Europe Market Attractiveness Analysis, By Product Type, 2021–2031 Figure 49: Europe Market Attractiveness Analysis, By Indication, 2021–2031 Figure 50: Europe Market Attractiveness Analysis, By End User, 2021–2031 Figure 51: Europe Market Attractiveness Analysis, By Country, 2020–2030 Figure 52: South Asia Market Share, By Product Type (2021) Figure 53: South Asia Market Share, By Indication (2021) Figure 54: South Asia Market Share, By End User (2021) Figure 55: South Asia Market Share, By Country (2021) Figure 56: South Asia Market Value (US$ Mn) Analysis, 2016-2020 Figure 57: South Asia Market Value (US$ Mn) & Y-o-Y Growth (%), 2021-2031 Figure 58: South Asia Market Attractiveness Analysis, By Product Type, 2021–2031 Figure 59: South Asia Market Attractiveness Analysis, By Indication, 2021–2031 Figure 60: South Asia Market Attractiveness Analysis, By End User, 2021–2031 Figure 61: South Asia Market Attractiveness Analysis, By Country, 2020–2030 Figure 62: East Asia Market Share, By Product Type (2021) Figure 63: East Asia Market Share, By Indication (2021) Figure 64: East Asia Market Share, By End User (2021) Figure 65: East Asia Market Share, By Country (2021) Figure 66: East Asia Market Value (US$ Mn) Analysis, 2016-2020 Figure 67: East Asia Market Value (US$ Mn) & Y-o-Y Growth (%), 2021-2031 Figure 68: East Asia Market Attractiveness Analysis, By Product Type, 2021–2031 Figure 69: East Asia Market Attractiveness Analysis, By Indication, 2021–2031 Figure 70: East Asia Market Attractiveness Analysis, By End User, 2021–2031 Figure 71: East Asia Market Attractiveness Analysis, By Country, 2020–2030 Figure 72: Oceania Market Share, By Product Type (2021) Figure 73: Oceania Market Share, By Indication (2021) Figure 74: Oceania Market Share, By End User (2021) Figure 75: Oceania Market Share, By Country (2021) Figure 76: Oceania Market Value (US$ Mn) Analysis, 2016-2020 Figure 77: Oceania Market Value (US$ Mn) & Y-o-Y Growth (%), 2021-2031 Figure 78: Oceania Market Attractiveness Analysis, By Product Type, 2021–2031 Figure 79: Oceania Market Attractiveness Analysis, By Indication, 2021–2031 Figure 80: Oceania Market Attractiveness Analysis, By End User, 2021–2031 Figure 81: Oceania Market Attractiveness Analysis, By Country, 2020–2030 Figure 82: Middle East and Africa Market Share, By Product Type (2021) Figure 83: Middle East and Africa Market Share, By Indication (2021) Figure 84: Middle East and Africa Market Share, By End User (2021) Figure 85: Middle East and Africa Market Share, By Country (2021) Figure 86: Middle East and Africa Market Value (US$ Mn) Analysis, 2016-2020 Figure 87: Middle East and Africa Market Value (US$ Mn) & Y-o-Y Growth (%), 2021-2031 Figure 88: Middle East and Africa Market Attractiveness Analysis, By Product Type, 2021–2031 Figure 89: Middle East and Africa Market Attractiveness Analysis, By Indication, 2021–2031 Figure 90: Middle East and Africa Market Attractiveness Analysis, By End User, 2021–2031 Figure 91: Middle East and Africa Market Attractiveness Analysis, By Country, 2020–2030 Figure 92: U.S. Market Share Analysis (%) By Product Type, 2020 & 2031 Figure 93: U.S. Market Share Analysis (%) By Indication, 2020 & 2031 Figure 94: U.S. Market Share Analysis (%) By End User, 2020 & 2031 Figure 95: U.S Market Value Analysis (US$ Mn), 2020 & 2030 Figure 96: Canada Market Share Analysis (%) By Product Type, 2020 & 2031 Figure 97: Canada Market Share Analysis (%) By Indication, 2020 & 2031 Figure 98: Canada. Market Share Analysis (%) By End User, 2020 & 2031 Figure 99: Canada Market Value Analysis (US$ Mn), 2020 & 2030 Figure 100: Brazil Market Share Analysis (%) By Product Type, 2020 & 2031 Figure 101: Brazil Market Share Analysis (%) By Indication, 2020 & 2031 Figure 102: Brazil Market Share Analysis (%) By End User, 2020 & 2031 Figure 103: Brazil Market Value Analysis (US$ Mn), 2020 & 2031 Figure 104: UK Market Share Analysis (%) By Product Type, 2020 & 2031 Figure 105: UK Market Share Analysis (%) By Indication, 2020 & 2031 Figure 106: UK. Market Share Analysis (%) By End User, 2020 & 2031 Figure 107: UK Market Value Analysis (US$ Mn), 2020 & 2031 Figure 108: Germany Market Share Analysis (%) By Product Type, 2020 & 2031 Figure 109: Germany Market Share Analysis (%) By Indication, 2020 & 2031 Figure 110: Germany Market Share Analysis (%) By End User, 2020 & 2031 Figure 111: Germany Market Value Analysis (US$ Mn), 2020 & 2031 Figure 112: France Market Share Analysis (%) By Product Type, 2020 & 2031 Figure 113: France Market Share Analysis (%) By Indication, 2020 & 2031 Figure 114: France Market Share Analysis (%) By End User, 2020 & 2031 Figure 115: France Market Value Analysis (US$ Mn), 2020 & 2031 Figure 116: Spain Market Share Analysis (%) By Product Type, 2020 & 2031 Figure 117: Spain Market Share Analysis (%) By Indication, 2020 & 2031 Figure 118: Spain Market Share Analysis (%) By End User, 2020 & 2031 Figure 119: Spain Market Value Analysis (US$ Mn), 2020 & 2031 Figure 120: Italy Market Share Analysis (%) By Product Type, 2020 & 2031 Figure 121: Italy Market Share Analysis (%) By Indication, 2020 & 2031 Figure 122: Italy Market Share Analysis (%) By End User, 2020 & 2031 Figure 123: Italy Market Value Analysis (US$ Mn), 2020 & 2031 Figure 124: India Market Share Analysis (%) By Product Type, 2020 & 2031 Figure 125: India Market Share Analysis (%) By Indication, 2020 & 2031 Figure 126: India Market Share Analysis (%) By End User, 2020 & 2031 Figure 127: India Market Value Analysis (US$ Mn), 2020 & 2031 Figure 128: China Market Share Analysis (%) By Product Type, 2020 & 2031 Figure 129: China Market Share Analysis (%) By Indication, 2020 & 2031 Figure 130: China Market Share Analysis (%) By End User, 2020 & 2031 Figure 131: China Market Value Analysis (US$ Mn), 2020 & 2031 Figure 132: Japan Market Share Analysis (%) By Product Type, 2020 & 2031 Figure 133: Japan Market Share Analysis (%) By Indication, 2020 & 2031 Figure 134: Japan Market Share Analysis (%) By End User, 2020 & 2031 Figure 135: Japan Market Value Analysis (US$ Mn), 2020 & 2031
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
